OnPoint Vision Closes Initial Financing

Advised OnPoint Vision, Inc. in its initial closing of a maximum $6.5 million preferred stock financing. The initial closing coincided with the initial capitalization of OnPoint Vision, Inc. which included the contribution of certain IP assets as well as an initial cash investment by Refocus Group, Inc.

OnPoint Vision was created to develop and commercialize intraocular pseudophakic contact lens products.  Refocus Group Inc. is a pioneer in vision-correcting technology and is the developer of the VisAbility™ Micro Insert System, an investigational medical device currently undergoing clinical trials in the United States, which may be able to restore the natural ability to focus on objects up close and eliminate the need for reading glasses.